BML Investment Partners, L.P. 13D and 13G filings for Talis Biomedical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-14 9:23 pm Purchase | 2024-08-14 | 13G | Talis Biomedical Corporation TLIS | BML Investment Partners, L.P. | 203,569 11.200% | 69,484 (+51.82%) | Filing |
| 2024-08-14 8:44 pm Purchase | 2024-08-07 | 13G | Talis Biomedical Corporation TLIS | BML Investment Partners, L.P. | 134,085 7.400% | 134,085 (New Position) | Filing |